Issued 2026-09-16 at $10.32 · now $10.32 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, HCMA has typically landed between $10.20 and $10.54 — a range of −1.2% to +2.2% from the issuance price $10.32.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
716 overlapping 1 month windows · 2022-03-16 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($10.32) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where HCMA has typically landed a month from the 2026-09-16 close of $10.32 — the range is history, not a prediction.
- now $10.32 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $10.37 (+0.5%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $10.33–$10.41
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $10.2–$10.54
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2024-02-01 | −59.0% | −59.0% | +0.5% |
| 2024-02-02 | −55.9% | −58.6% | +1.5% |
| 2024-01-31 | −55.6% | −55.6% | +2.2% |
| 3 best | |||
| 2024-03-04 | +115.6% | +0.0% | +209.2% |
| 2024-03-05 | +102.0% | +0.0% | +190.0% |
| 2024-03-01 | +101.8% | −6.2% | +190.0% |
716 overlapping windows · 2022-03-16 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~3 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
4 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2025-07-31 | Matthews Shawn | director | Other acquisition | 75,000 | 8,358,333 | Form 4 |
| 2025-07-31 | Loveless Jacob | director | Other acquisition | 25,000 | 25,000 | Form 4 |
| 2025-07-31 | Donohoe Richard Charles | director | Other acquisition | 25,000 | 25,000 | Form 4 |
| 2025-07-31 | Goos Craig | director | Other acquisition | 25,000 | 25,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.